ArticleOncoimmunology2025

Low triglyceride levels are associated with increased risk of immune-related adverse events in patients receiving immune checkpoint inhibitors.

Nora Möhn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.